Covista Inc. (CVSA): what the price assumes

In the published model solve dated 2026-Q2, anchored at $128.09, Covista Inc. (CVSA) is priced for -4.9% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/CVSA

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

The operating-margin figure is value-band context at year 11: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Relative, Growth Families that call it expensive: Asset

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.8%); the inversion above states its own rate.

Per-Model Detail (n=15)

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

Bullet Takeaways

• Essentially all revenue is tuition, split across three healthcare-focused schools: Chamberlain at $197.0 million of March-quarter revenue, Walden at $186.6 million, and the medical and veterinary schools at $103.5 million.

• The dominant risk is federal rather than commercial, and the 10-K says so directly: "Our ability to comply with several ED regulations is not entirely within our control", and a programme failing the government's outcomes test twice in three years loses access to federal student aid.

• Fourth quarter and full-year results are due August 6, 2026, following a May report at which management raised its full-year earnings guidance.

Bull Case

One academic week moved out of the March quarter and into the December quarter. That single scheduling decision held Walden's reported revenue growth to 4.6% for the period. Without it, the filing states, segment revenue would have risen 14.7% to $204.6 million rather than $186.6 million, and consolidated revenue would have been $505.0 million rather than $487.0 million. A model reading the quarterly series cannot see that. It sees a slowdown. The school saw a calendar.

The same mismatch operates at a larger scale, which is where the bull case actually lives. Read the label and this is a for-profit education company, a description that comes with a great deal of accumulated baggage. Read the revenue and it is nursing degrees, medical degrees and veterinary degrees sold into a shortage of the people who hold them. The 10-K is explicit about the mechanism behind the smallest and fastest-growing piece: institutions have expanded capacity "because of the growing supply/demand imbalance for medical doctors and veterinarians", and even so, "management believes the imbalance will continue to spur demand for medical and veterinary education". That segment grew 8.9% to $103.5 million in the March quarter, the fastest of the three.

The margin settles which kind of company this is. Trailing operating margin runs 19.7%, on revenue of about 1.91 billion. Inside the cohort, STRA earns 13.8% on $1.271 billion of revenue and LRN earns 15.8% on $2.536 billion, while the most selective operators run higher: LOPE at 24.3% on $1.126 billion, PRDO at 24.3% on $854.8 million, LAUR at 24.0% on $1.738 billion. This one sits in the upper half of that spread while carrying the second-largest revenue base among the pure-play schools. Twenty cents of operating profit on the tuition dollar is not what a structurally declining business looks like.

Capital allocation is the part that cannot be argued with. The share count has fallen about 8.4% a year across four years. Compounded, that retires close to three shares in every ten, and every holder who did nothing now owns a proportionally larger claim on the same tuition stream. Buybacks at that pace are a statement about where management believes value sits, made in a currency that cannot be revised in a later press release. Free cash flow of $336.3 million over the trailing year is what paid for it. Set that beside trailing operating profit of $378.4 million and almost the whole of the reported profit turned into spendable funds rather than into receivables.

Finally, the trailing year is better than the record rather than worse. The five-year average operating profit, with one-time charges added back, comes to about 240 million, against the 378.4 million just produced. Most of the backward-looking valuation lenses average across that older, thinner period. The business they are pricing is not the business currently filing.

Bear Case

Nearly every tuition dollar this company collects passes through a federal aid programme before it arrives. That single dependency is the whole risk, and the 10-K does not soften it: "Our ability to comply with several ED regulations is not entirely within our control", because eligibility rests on "the ability of our past students to avoid default on student loans, obtain sufficiently remunerative employment". Under the outcomes rules, "programs that fail the same measure in two out of three consecutive years lose Title IV eligibility". That is not a penalty to be paid and absorbed. It is the removal of the payment channel for the programme concerned, and no amount of operational excellence prevents a student cohort from graduating into a weak labour market.

The peer filings show what that risk looks like when it lands on somebody. STRA discusses borrower defense applications tied to Capella University and warns that if the Department "were to successfully seek recovery for the amounts of discharged loans from Capella University in future proceedings, any such recovery could have a material adverse effect on our business". LOPE describes student loan access and cost as remaining "in a state of flux", and notes that any resolution raising loan costs or restricting access "could reduce student demand for educational programs". These are not hypothetical clauses drafted by cautious lawyers. They are live proceedings at companies selling the same product.

Set that against what the price already assumes, because the answer complicates the bear rather than helping it. At $115.67 the market is not paying for expansion. The valuation is consistent with operating profit shrinking roughly 4.3% a year for five years. On its face that is pessimism already in the quote. The difficulty is what the pessimism is aimed at. A gradual decline can be discounted at a rate. A rule change that strips a programme's funding is a step, not a slope, and a discount rate handles steps badly. The price may be low and still be wrong, because the distribution it is pricing has a tail that no growth rate describes.

The operating detail underneath is more mixed than the consolidated line suggests. Chamberlain, the largest school, grew revenue 2.3% in the March quarter to $197.0 million. Walden grew 4.6% as reported. Only the medical and veterinary schools grew at a healthy clip, and those carry physical campuses in Barbados, St. Kitts and St. Maarten holding $131.4 million of long-lived assets, a cost structure with far less flexibility than an online nursing programme when enrolment turns. Competition is not thin either. The filing observes that Walden "competes with a wide variety of higher education institutions as well as other education providers", including traditional public and private non-profits with cost bases that do not need to earn a return.

The capital structure narrows the room for a bad year. Borrowings less liquid assets come to roughly 352 million dollars on the funded-debt measure and roughly 578 million once lease obligations are counted alongside them. Retiring close to three shares in ten over four years while carrying that is a bet on the durability of the tuition stream. It is a defensible bet and it has worked so far. It is also the same bet the regulatory exposure is designed to make you think twice about, and a company that has already spent the buyback has fewer moves left if the rules change.

Valuation

Read the price backwards and it says something you do not see often. At $115.67 a share, with borrowings included, the whole enterprise is carried at roughly 4.5 billion dollars against operating profit of $378.4 million over the trailing year. To make that arithmetic work, the business does not need to grow. It needs its operating profit to fall about 4.3% a year for five years and still be worth what is being paid today. The market is not asking this company to expand. It is assuming it contracts, and pricing accordingly.

The methods line up with that assumption in a consistent way. The forward cash-flow approaches land well above the price, because they credit the recent record rather than a decline: one projects roughly 10% growth over six years before settling at a 4.0% terminal rate, and the closer of the two simply holds the exit multiple flat at today's 11.3 in its base case, compressing to 9.3 in the bear scenario and expanding to 13.3 in the bull. Neither construction is exotic. Both take the recent record at face value, which is precisely what the price declines to do. The peer-multiple reading lands almost exactly on the quote.

The two lenses that put the price above what they support are the book-value and earnings-power ones, and both are reading an older company. The five-year average operating profit with one-time charges added back comes to about 240 million, well under the 378.4 million the trailing year produced. Capitalize the average and the price looks about 55% above where the earnings-power reading sits; capitalize what the business actually earned last year and the gap closes substantially. This company is more profitable now than it has typically been, which makes any historical-average frame read expensive by construction rather than by judgement.

The cohort sharpens rather than softens the point. Measured against the multiple range the education group occupies, this name sits in the lower half. On operating margin it does not: 19.7% on a trailing basis against STRA at 13.8% on $1.271 billion of revenue and LRN at 15.8% on $2.536 billion, though below LOPE at 24.3% and LAUR at 24.0%. A better-than-median margin at a below-median multiple describes a business the market distrusts rather than one it thinks is failing, and the distrust has an address: the federal aid channel every one of these companies depends on.

Solvency is not the pressure point. Net obligations run near 352 million dollars on the funded-debt build and near 578 million once lease commitments are counted with them, against operating profit that covers the interest bill with substantial room and free cash flow of $336.3 million over the trailing year. The most concrete number in the whole file is the share count, which has fallen about 8.4% a year for four years. A holder who bought then and did nothing since owns a materially larger slice of the same tuition today. Against a price that assumes the profit shrinks, that particular arithmetic runs the other way.

Catalysts

Fourth quarter and full-year results arrive on August 6, 2026. Two things carry the information. The first is whether Chamberlain's revenue growth, 2.3% in the March quarter, reaccelerates or settles at that pace; it is the largest of the three schools and the one whose enrolment trend most directly sets the consolidated line. The second is the guidance range itself. Management raised its full-year earnings outlook at the May 7 report, so the August print either confirms that raise or walks it back, and there is no third option.

Physical expansion has resumed on the nursing side. Chamberlain announced a new campus in Salt Lake City, Utah on July 24, 2026. New campuses are slow-burning items: they consume capital and staffing before they enrol at scale, so the near-term effect on the margin is negative and the payoff sits several years out. It is worth watching as a signal about where management sees enrolment demand rather than as anything that moves the next few quarters.

Two workforce items in the past month point at the same strategy. On June 29, 2026 the company launched a nursing collaboration with Advocate Health aimed at workforce readiness, and on July 13, 2026 it committed 10 million dollars and 50,000 volunteer hours to healthcare workforce development. Partnerships with hospital systems matter more than the dollar figures attached to them, because clinical placement capacity is the practical constraint on how many nursing students an institution can actually enrol. A programme that secures placements can grow. One that cannot, cannot, regardless of how many applications it receives.

Peer Cohorts (Per Segment, With Filing Citations)

Chamberlain (reported)

• STRA (Strategic Education, Inc.)
• FY2025 10-K: …time, the Company is unable to predict the ultimate outcome of Capella-related borrower defense applications. If the Department were to successfully seek recovery for the amounts of discharged loans from Capella University in future proceedings, any such recovery could have a material adverse effect on our business.…
• FY2025 10-K: …Options and Technical Extensions ("REMOTE") Act. Capella University and Strayer University participate in DOD military tuition assistance programs under Memoranda of Understanding ("MOU"). Strayer University's current MOU was executed on September 4, 2024 for a five-year period. Capella University's current MOU was…
• LOPE (Grand Canyon Education, Inc.)
• FY2025 10-K: …access to and the costs of student loans remains in a state of flux. The uncertainty surrounding these issues, and any resolution of these issues that increases loan costs or reduces students' access to Title IV loans or to student extended payment plans, could reduce student demand for educational programs which…
• FY2025 10-K: …May 2, 2023. ​ ​ ​ ​ ​ 10.8 ​ Second Amended and Restated Executive Employment Agreement, dated April 29, 2025, by and between Grand Canyon Education, Inc. and Kathy J. Claypatch † ​ Incorporated by reference to Exhibit 10.1 to the Company Quarterly Report on Form 10-Q filed on May 6, 2025. ​ ​ ​ ​ ​ 10.9 ​ Form of…
• LAUR (Laureate Education, Inc.)
• FY2025 10-K: …us-gaap:SecuredOvernightFinancingRateSofrMember laur:ThirdAmendmentMember us-gaap:LineOfCreditMember 2023-09-18 2023-09-18 0000912766 us-gaap:SecuredDebtMember laur:EuroInterbankOfferedRateEURIBORMember laur:ThirdAmendmentMember us-gaap:LineOfCreditMember 2023-09-18 2023-09-18 0000912766 us-gaap:SecuredDebtMember…
• FY2025 10-K: 30/2025 19 Laureate Education, Inc. Insider Trading Policy 10-K 001-38002 19 02/20/2025 21.1* List of Subsidiaries of the Registrant 23.1* Consent of PricewaterhouseCoopers LLP 31.1* Certification pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002 31.2* Certification pursuant to Section 302 of the…
• PRDO (Perdoceo Education Corporation)
• FY2025 10-K: Patrick Gross and Leslie Thornton. The Committee reviews information security matters quarterly. In addition, the full Board regularly receives updates on cybersecurity matters from our Chief Information Officer, David C. Czeszewski, at each board meeting. The Chief Information Officer reports on, among other things,…
• FY2025 10-K: …schedule of substantially identical agreements with the attorneys general of other states Exhibit 10.2 to our Form 10-Q for the period ended March 31, 2019 10.31 Stipulated Order for Permanent Injunction and Monetary Judgment dated October 9, 2019 agreed to by the Federal Trade Commission and Career Education…
• GHC (GRAHAM HOLDINGS CO)
• FY2025 10-K: …2023-01-01 2023-12-31 0000104889 us-gaap:OperatingSegmentsMember us-gaap:ReportableSubsegmentsMember ghc:CSIPharmacyMember ghc:HealthcareDivisonMember 2023-01-01 2023-12-31 0000104889 us-gaap:OperatingSegmentsMember ghc:OtherHealthcareMember ghc:HealthcareDivisonMember 2023-01-01 2023-12-31 0000104889…
• FY2025 10-K: …phishing exercises quarterly. Some employees receive additional in-depth training related to their individual job responsibilities. Item 2. Properties. The Company leases space for its corporate offices in Arlington, V A. Kaplan owns a total of six properties, including four in the U.S. and one property in South…
• LRN (Stride, Inc.)
• FY2025 10-K: …confirms all said attorneys-in-fact and agents, each acting alone, and his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Exchange Act of 1934 this report has been signed below by the following persons on behalf of the registrant…
• FY2025 10-K: 1157408 us-gaap:DevelopedTechnologyRightsMember 2025-06-30 0001157408 us-gaap:CustomerRelationshipsMember 2025-06-30 0001157408 us-gaap:TradeNamesMember 2024-06-30 0001157408 us-gaap:OtherIntangibleAssetsMember 2024-06-30 0001157408 us-gaap:DevelopedTechnologyRightsMember 2024-06-30 0001157408…
• UTI (UNIVERSAL TECHNICAL INSTITUTE, INC)
• FY2025 10-K: …Registrant's Quarterly Report on Form 10- Q filed with the SEC on May 8, 2025). 19.10 Insider Trading Policy (incorporated by reference to Exhibit 19.1 to the Form 10-K filed with the SEC on December 5, 2024). 21.1+ Subsidiaries of the Registrant. 23.1+ Consent of Deloitte & Touche LLP. 24.1 Power of Attorney…
• FY2025 10-K: …Principal Financial Officer of the Company required by Section 302 of the Sarbanes-Oxley Act of 2002. The Company has submitted to the NYSE the most recent Annual Chief Executive Officer Certification as required by Section 303A.12(a) of the NYSE Listed Company Manual. ITEM 9B. OTHER INFORMATION On August 21, 2025 ,…

Walden (reported)

• STRA (Strategic Education, Inc.)
• FY2025 10-K: The Department subsequently confirmed it would not take any enforcement action or otherwise implement the guidance until further notice. On October 15, 2025, the Department filed a notice of appeal to the U.S. Court of Appeals for the Fourth Circuit; and on January 21, 2026, the parties filed a joint motion to dismiss…
• FY2025 10-K: …is a fund management company with over $2 trillion under active management, having retired from that position on August 31, 2022. He continued to serve as Vice Chairman of Capital International Fund until his retirement from that position in 2023. He previously held several senior positions in the Australian…
• LOPE (Grand Canyon Education, Inc.)
• FY2025 10-K: ​ ​ ​ ​ ​ ​ ​ As of December 31, (In thousands, except par value) ​ 2025 ​ 2024 ​ ​ ​ ​ ​ ​ ASSETS: ​ ​ ​ ​ ​ ​ Current assets ​ ​ ​ ​ Cash and cash equivalents ​ $ 111,762 ​ $ 324,623 Investments ​ 188,317 ​ - Accounts receivable, net ​ 84,278 ​ 82,948 Income tax receivable ​ 2,392 ​ 490 Other current assets ​ 13,430…
• FY2025 10-K: ​ Title ​ ​ ​ Date ​ ​ ​ ​ ​ /s/ Brian E. Mueller ​ Chief Executive Officer and Chairman ​ February 18, 2026 Brian E. Mueller ​ (Principal Executive Officer) ​ ​ ​ ​ ​ ​ ​ /s/ Daniel E. Bachus ​ Chief Financial Officer ​ February 18, 2026 Daniel E. Bachus ​ (Principal Financial Officer) ​ ​ ​ ​ ​ ​ ​ /s/ Lori Browning…
• LAUR (Laureate Education, Inc.)
• FY2025 10-K: …of $3.7 million, from $20.3 million in 2023 to $16.6 million in 2024, attributable to lower average debt balances in 2024 compared to 2023. In addition, higher operating income combined with the net effect of changes in operating assets and liabilities increased operating cash flows by $1.7 million compared to 2023.…
• FY2025 10-K: Company sold to the Walden Purchaser all of the issued and outstanding equity interest in Walden e-Learning, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (Walden), and its subsidiary, Walden University, LLC, a Florida limited liability company and an indirect wholly owned…
• PRDO (Perdoceo Education Corporation)
• FY2025 10-K: 2-31 0001046568 prdo:TitleFourFundsMember 2024-12-31 0001046568 prdo:AIUSMember prdo:AdmissionsMember 2023-01-01 2023-12-31 0001046568 prdo:DepreciationAndAmortizationMember prdo:USAHSMember 2024-01-01 2024-12-31 0001046568 prdo:AshishGhiaMember 2025-10-01 2025-12-31 0001046568 srt:MaximumMember 2025-01-01 2025-12-31…
• FY2025 10-K: …prdo:BadDebtMember 2025-01-01 2025-12-31 0001046568 prdo:UniversityOfStAugustineForHealthSciencesLlcMember prdo:UniversityGroupMember prdo:TuitionAndFeesNetMember 2025-01-01 2025-12-31 0001046568 us-gaap:CommonStockMember 2022-12-31 0001046568 us-gaap:StateAndLocalJurisdictionMember 2024-12-31 0001046568…
• GHC (GRAHAM HOLDINGS CO)
• FY2025 10-K: …Honda of Woodbridge in Virginia. The Company has a management services agreement with an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships, to operate and manage the operations of the dealerships. The Company also owns Roda, which provides valet automotive…
• FY2025 10-K: …us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember 2025-12-31 0000104889 us-gaap:FairValueMeasurementsRecurringMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember 2025-12-31 0000104889…
• LRN (Stride, Inc.)
• FY2025 10-K: …2024-07-01 2025-06-30 0001157408 lrn:PerformanceSharesTrancheTwoMember lrn:FiscalYear2024LongTermIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-07-01 2024-06-30 0001157408 lrn:PerformanceSharesTrancheOneMember lrn:FiscalYear2024LongTermIncentivePlanMember…
• FY2025 10-K: 30 0001157408 2024-06-30 0001157408 lrn:FoundationForOnlineAndBlendedLearningMember 2025-06-30 0001157408 lrn:FoundationForOnlineAndBlendedLearningMember 2021-06-30 0001157408 lrn:FoundationForOnlineAndBlendedLearningMember 2019-06-30 0001157408 lrn:StudentAndStateTestingComputersMember 2024-07-01 2025-06-30…

Medical and Veterinary (reported)

• STRA (Strategic Education, Inc.)
• FY2025 10-K: …90 days but less than six months of active-duty service. Additionally, the bill restores VA education benefits to students who were enrolled in schools that closed after January 2015 if their credits did not transfer. On January 5, 2021, the Veterans Health Care and Benefits Improvement Act of 2020 became law, which…
• FY2025 10-K: …Corporation. From 1985 to 1997, with the exception of 1990 to 1991 when he was on a leave of absence to serve as a White House Fellow and Assistant for Special Projects to the Secretary of Defense, Mr. Grusky served in a variety of capacities at Goldman, Sachs & Co., first in its Mergers & Acquisitions Department and…
• LOPE (Grand Canyon Education, Inc.)
• FY2025 10-K: 2024 primarily due to our ability to leverage our counseling services and support expenses across an increasing revenue base. We anticipate that counseling services and 54 Table of Contents support expense will increase in the future as we continue to invest to meet our partners' needs and these costs as a percentage…
• FY2025 10-K: …May 2, 2023. ​ ​ ​ ​ ​ 10.8 ​ Second Amended and Restated Executive Employment Agreement, dated April 29, 2025, by and between Grand Canyon Education, Inc. and Kathy J. Claypatch † ​ Incorporated by reference to Exhibit 10.1 to the Company Quarterly Report on Form 10-Q filed on May 6, 2025. ​ ​ ​ ​ ​ 10.9 ​ Form of…
• LAUR (Laureate Education, Inc.)
• FY2025 10-K: …not effectively manage our growth and business, our results of operations may be materially adversely affected." Regulatory Environment and Other Matters Our business is subject to varying laws and regulations based on the requirements of local jurisdictions. These laws and regulations are subject to updates and…
• FY2025 10-K: Cardoso and MC Consultoria and Assesoria Empresarial LTDA 10-K 001-38002 10.43 02/23/2023 10.35† Second Amendment to Independent Contractor and Consultant Agreement as of March 1, 2022 between Laureate Education, Inc. and MC Consultoria and Assesoria Empresarial LTDA 10-K 001-38002 10.44 02/23/2023 10.36† Third…
• PRDO (Perdoceo Education Corporation)
• FY2025 10-K: …Area Accredited (2) ABET Colorado Technical University, Colorado Springs Electrical engineering and computer engineering Accreditation Council for Business Schools and Programs AIUS: American InterContinental University (all locations), California Southern University and Trident University International; Colorado…
• FY2025 10-K: …commencing in May 2016) Exhibit 10.3 to our Form 8-K filed on May 27, 2016 *10.16 Form of Employee Restricted Stock Unit Award Agreement under the 2016 Plan (Performance-Based) (used for awards commencing in May 2016) Exhibit 10.4 to our Form 8-K filed on May 27, 2016 *10.17 Form of Non-Employee Director Restricted…
• AFYA (AFYA LIMITED)
• FY2025 20-F: …sales of e-books which are recognized at the point in time when control is transferred to the customer, which is generally concentrated in the first and last quarter of the year due to the period of enrollments. Consequently, the Continuing Education segment generally has higher revenues and results of operations in…
• FY2025 20-F: …that provide technical medical content, professional development tools and specialized training resources for physicians and medical students. These platforms offer a broad range of educational materials, including structured courses, mentoring programs for medical residency preparation, specialty training programs…
• GHC (GRAHAM HOLDINGS CO)
• FY2025 10-K: …and Exchange Visitor Program (SEVP) for attendance by students with F-1 visas. Separately, Kaplan Medical Education, offers online continuing medical education for physicians, nurses and pharmacists which is accredited by Joint Accreditation for Interprofessional Continuing Education. Finance and Real Estate Segment.…
• FY2025 10-K: …other G&A expenses. (c) Supplemental education - training and employment expense, operating fees and other G&A expenses. The Company's healthcare division segment information is as follows: Year Ended December 31, 2025 (in thousands) CSI Other Healthcare Total Healthcare Operating Revenues $ 465,508 $ 349,541 $…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.